What does Belfar do?
BELFAR specializes in the production and distribution of high-quality pharmaceuticals and healthcare products. The company is committed to innovation and sustainability in its operations, ensuring that it meets the evolving needs of the healthcare market. Through strategic partnerships and a robust supply chain, BELFAR aims to enhance patient care and improve health outcomes worldwide.
- Sectors
- Holding companies
- Activities
- Signals
-
Reporting lossesReporting losses € -6K
The company reported a loss in the latest financial year.
Poor liquidityPoor liquidity 0.23The current ratio is below 1: may be insufficient to cover short-term debt.
Negative cashflowNegative cashflow € -18KOperating cash flow was negative in the latest financial year.
Negative EBITDANegative EBITDA € -6KEBITDA is negative: operating activities are loss-making.
Strong equityStrong equity € 3.16MStrong equity provides a buffer against setbacks.
Low riskLow risk 72.9%Good solvency (> 30%) points to long-term financial stability.
- Shareholders
- Elimi 49,95%, Tesa Invest
- Investments
- E&E Safety & Consulting 100%, Imopa 99,94%
Financial ratios
|
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
€
-5K
|
€
245K
|
€
83K
|
€
23K
|
|
|
€
-6K
|
€
244K
|
€
55K
|
€
22K
|
|
|
€
-18K
|
€
229K
|
€
29K
|
€
5K
|
|
|
€
3.16M
|
€
3.18M
|
€
2.95M
|
€
2.92M
|
|
|
72.88%
|
72.98%
|
66.72%
|
63.4%
|
|
|
€
1.18M
|
€
1.18M
|
€
1.47M
|
€
1.69M
|
|
|
€
60K
|
€
47K
|
€
54K
|
€
233K
|
Publications 37
All publications- Ontslagen - Benoemingen - Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) 30/04/2024
- Ontslagen - Benoemingen 04/01/2023
- Ontslagen - Benoemingen 11/02/2020
- Me. - Jaarrekening 30.06.2016, Ggk 12.12.2016, Ngl 16.01.2017 17013-0314-011 20/01/2017
- Me. - Jaarrekening 30.06.2015, Ggk 14.12.2015, Ngl 14.01.2016 16012-0415-011 18/01/2016
Frequently asked questions
Answers to the most common questions about Belfar, based on official government data and the filed annual accounts.
What is the VAT number of Belfar?
The VAT number of Belfar is BE0444.292.068.
When was Belfar established?
Belfar was founded in 24-05-1991.
What is the official address of Belfar?
The official address of Belfar is Hertevoetweg 34 Zemst 1982.
What is the legal form of Belfar?
The juridical form of Belfar is Public limited company (NV/SA).
What is the annual revenue of Belfar?
The 2025 accounts of Belfar do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
What does Belfar do?
BELFAR specializes in the production and distribution of high-quality pharmaceuticals and healthcare products. The company is committed to innovation and sustainability in its operations, ensuring that it meets the evolving needs of the healthcare market. Through strategic partnerships and a robust supply chain, BELFAR aims to enhance patient care and improve health outcomes worldwide.
Is Belfar a reliable company?
Belfar is a registered Rechtspersoon with company number 0444.292.068 and can be verified through the official CBE database.
What is the credit limit of Belfar?
The estimated credit limit of Belfar is €135,112.
Is Belfar still active?
Belfar currently has the status "Normal situation" and is active.